⌘K

12:15:46·1236d

13D/GFilingvia Quantisnow

SEC Form SC 13G/A filed by Seres Therapeutics Inc. (Amendment)

ByQuantisnow·Wall Street's wire, on your screen.

MCRB· Seres Therapeutics Inc.

Health Care

Original source

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

SEC Form 8-K filed by Seres Therapeutics Inc.
Seres Therapeutics Announces Two Transactions to Strengthen Balance Sheet, Reduce On-Going Lease Costs and Extend Projected Operating Cash Runway Well Into the First Quarter of 2027
SEC Form 8-K filed by Seres Therapeutics Inc.
Officer Brady Kelly converted options into 180 shares and sold $444 worth of shares (59 units at $7.53), increasing direct ownership by 1% to 8,562 units (SEC Form 4)
Officer Henn Matthew R converted options into 238 shares and sold $580 worth of shares (77 units at $7.53) as part of a pre-agreed trading plan, increasing direct ownership by 2% to 7,838 units (SEC Form 4)

SEC Form SC 13G/A filed by Seres Therapeutics Inc. (Amendment) | Quantisnow